Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

AI/ML

Health Care

Nucleai

Nucleai's headquarters in Tel Aviv, Israel

Avi Veidman

Elad Amsalem

Mor Kenigsbuch

Gali Golan

Dudi Benayoun

Neta-Etel Bukay

Yael Tochner

Dani Zeevi

Mor Golan

Aviv Levi

Hagar Sachs

Neelima Kumar

Jonathan Daniels

Lotan Chorev

Liat Ben-Senior MBA MSc

Golan Mizrahi

Ettai Markovits

Julian Adams

Hossein Borghaei

Alexander J. Lazar

Yuval Dimnik

Tom Gibbs

Andrew Harrison

Michael Pellini

Ester Abels

Anna Pokorska-Bocci

Suzana Cuoto

Cris De Luca

Noga Yerushalmi

Renana Ashkenazi

Emanuel Timor

Description

People (28)

Avi Veidman

Ettai Markovits

Golan Mizrahi

Gali Golan

Mor Kenigsbuch

Yael Tochner

Alon Groisman

Rivka Becky A.

Efrat Dicker Sagy

Lauren Alaluf

Luba Ilfeld

Mor Matalon

Ofek Arviv

Ron Elran

Roni Yichie

Shai Bookstein

Shani Caspi

Yuval Shachaf

Avital L. Polsky

sivan mayo

Moshe Gordon Radian

Gon Yishay

Zehavit Rachmiel Arison

Rotem Zwi

Keren Weinberg Bar-Lev

Romi Sadan

Danielle Cohen

Neta-Etel Bukay